AVR Stock Analysis: Buy, Sell, or Hold?
AVR - Anteris Technologies Global Corp. Common Stock
$10.28
0.69 (7.19%)
▲
5d:
+9.13%
30d:
+14.22%
90d:
+87.93%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When AVR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AVR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AVR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AVR is currently trading at $10.28, which is considered extended relative to its 30-day fair value range of $8.41 to $9.77.
Technical Outlook: Technically, AVR is in a strong uptrend. The price is approaching resistance at $10.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.33 (+59.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AVR is in a strong uptrend. The price is approaching resistance at $10.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.33 (+59.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.41 -
$9.77
Company Quality Score
63/100
(BUY)
Options IV Signal
40th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
55.0%
All Signals
- BEARISH: Price extended above range (+5.2% above its trading range)
- NEUTRAL: Options fairly priced (IV 40th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.2%)
- BULLISH: Trading 59.9% below Wall St target ($15.33)
Trading Range Analysis
30-Day Trading Range
$8.41 -
$9.77
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.99
(9.6%)
Support & Resistance Levels
Support Level
$8.85
Resistance Level
$10.56
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.79
Wall Street Target
$15.33
(+59.9%)
Revenue Growth (YoY)
-11.2%
Share & Embed Analysis
Last updated: June 23, 2026 4:18 PM ET
Data refreshes hourly during market hours. Next update: 5:18 PM
Data refreshes hourly during market hours. Next update: 5:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
L1 Capital Pty Ltd
BUY
5000000 shares
2026-01-22
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 54 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 50 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 65 BUY |
